鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/28 | 3,715 | 3,795 | 3,715 | 3,755 | -20 | -0.5% | 63,800 |
2020/01/27 | 3,700 | 3,830 | 3,670 | 3,775 | +5 | +0.1% | 86,200 |
2020/01/24 | 3,770 | 3,820 | 3,710 | 3,770 | +45 | +1.2% | 97,700 |
2020/01/23 | 3,605 | 3,795 | 3,605 | 3,725 | +75 | +2.1% | 167,600 |
2020/01/22 | 3,600 | 3,650 | 3,560 | 3,650 | +80 | +2.2% | 113,800 |
2020/01/21 | 3,500 | 3,645 | 3,485 | 3,570 | +280 | +8.5% | 320,400 |
2020/01/20 | 3,255 | 3,315 | 3,250 | 3,290 | +20 | +0.6% | 44,800 |
2020/01/17 | 3,220 | 3,290 | 3,220 | 3,270 | +55 | +1.7% | 46,300 |
2020/01/16 | 3,185 | 3,215 | 3,135 | 3,215 | +30 | +0.9% | 33,500 |
2020/01/15 | 3,200 | 3,215 | 3,155 | 3,185 | -10 | -0.3% | 21,900 |
2020/01/14 | 3,260 | 3,275 | 3,170 | 3,195 | -90 | -2.7% | 48,900 |
2020/01/10 | 3,145 | 3,285 | 3,145 | 3,285 | +175 | +5.6% | 85,000 |
2020/01/09 | 3,070 | 3,110 | 3,060 | 3,110 | +85 | +2.8% | 29,100 |
2020/01/08 | 3,000 | 3,045 | 2,924 | 3,025 | ±0 | ±0% | 57,600 |
2020/01/07 | 3,010 | 3,035 | 2,994 | 3,025 | +15 | +0.5% | 19,700 |
2020/01/06 | 3,015 | 3,030 | 2,994 | 3,010 | -50 | -1.6% | 35,600 |
2019/12/30 | 3,045 | 3,075 | 3,020 | 3,060 | +10 | +0.3% | 25,700 |
2019/12/27 | 2,952 | 3,050 | 2,952 | 3,050 | +59 | +2% | 44,400 |
2019/12/26 | 2,973 | 2,991 | 2,956 | 2,991 | +10 | +0.3% | 16,000 |
2019/12/25 | 2,991 | 2,998 | 2,972 | 2,981 | -10 | -0.3% | 8,900 |
2019/12/24 | 3,030 | 3,035 | 2,982 | 2,991 | -5 | -0.2% | 17,200 |
2019/12/23 | 3,030 | 3,030 | 2,996 | 2,996 | -24 | -0.8% | 12,200 |
2019/12/20 | 3,035 | 3,035 | 2,990 | 3,020 | -15 | -0.5% | 25,100 |
2019/12/19 | 3,015 | 3,035 | 2,994 | 3,035 | +53 | +1.8% | 20,800 |
2019/12/18 | 3,015 | 3,035 | 2,966 | 2,982 | -33 | -1.1% | 39,900 |
2019/12/17 | 2,998 | 3,030 | 2,998 | 3,015 | +28 | +0.9% | 41,400 |
2019/12/16 | 2,950 | 2,988 | 2,940 | 2,987 | +47 | +1.6% | 62,800 |
2019/12/13 | 2,938 | 2,960 | 2,910 | 2,940 | +49 | +1.7% | 69,100 |
2019/12/12 | 2,949 | 2,959 | 2,880 | 2,891 | -62 | -2.1% | 55,400 |
2019/12/11 | 2,964 | 2,991 | 2,940 | 2,953 | -4 | -0.1% | 46,800 |
2019/12/10 | 2,935 | 2,969 | 2,913 | 2,957 | +12 | +0.4% | 38,600 |
2019/12/09 | 2,899 | 2,949 | 2,891 | 2,945 | +59 | +2% | 60,100 |
2019/12/06 | 2,900 | 2,918 | 2,880 | 2,886 | -28 | -1% | 39,400 |
2019/12/05 | 2,900 | 2,920 | 2,885 | 2,914 | +9 | +0.3% | 38,200 |
2019/12/04 | 2,850 | 2,905 | 2,845 | 2,905 | +35 | +1.2% | 40,000 |
2019/12/03 | 2,840 | 2,880 | 2,840 | 2,870 | +19 | +0.7% | 34,300 |
2019/12/02 | 2,860 | 2,879 | 2,850 | 2,851 | -11 | -0.4% | 22,700 |
2019/11/29 | 2,878 | 2,888 | 2,851 | 2,862 | -3 | -0.1% | 27,900 |
2019/11/28 | 2,900 | 2,902 | 2,851 | 2,865 | -20 | -0.7% | 23,300 |
2019/11/27 | 2,908 | 2,933 | 2,877 | 2,885 | -18 | -0.6% | 31,600 |
2019/11/26 | 2,876 | 2,938 | 2,870 | 2,903 | +4 | +0.1% | 75,300 |
2019/11/25 | 2,900 | 2,909 | 2,877 | 2,899 | +10 | +0.3% | 42,900 |
2019/11/22 | 2,865 | 2,899 | 2,854 | 2,889 | +26 | +0.9% | 33,400 |
2019/11/21 | 2,918 | 2,918 | 2,859 | 2,863 | -35 | -1.2% | 47,200 |
2019/11/20 | 2,850 | 2,901 | 2,843 | 2,898 | +54 | +1.9% | 62,300 |
2019/11/19 | 2,808 | 2,860 | 2,804 | 2,844 | +41 | +1.5% | 53,500 |
2019/11/18 | 2,804 | 2,807 | 2,778 | 2,803 | +22 | +0.8% | 32,500 |
2019/11/15 | 2,784 | 2,794 | 2,756 | 2,781 | +32 | +1.2% | 33,400 |
2019/11/14 | 2,771 | 2,814 | 2,749 | 2,749 | -28 | -1% | 41,600 |
2019/11/13 | 2,820 | 2,820 | 2,771 | 2,777 | -35 | -1.2% | 27,500 |
1301~
1350
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム